304 related articles for article (PubMed ID: 36385524)
21. T cells and monocyte-derived myeloid cells mediate immunotherapy-related hepatitis in a mouse model.
Llewellyn HP; Arat S; Gao J; Wen J; Xia S; Kalabat D; Oziolor E; Virgen-Slane R; Affolter T; Ji C
J Hepatol; 2021 Nov; 75(5):1083-1095. PubMed ID: 34242700
[TBL] [Abstract][Full Text] [Related]
22. Phosphoinositide 3-kinase inhibitor LY294002 ameliorates the severity of myosin-induced myocarditis in mice.
Liu HS; Zhang J; Guo JL; Lin CY; Wang ZW
Curr Res Transl Med; 2016; 64(1):21-7. PubMed ID: 27140596
[TBL] [Abstract][Full Text] [Related]
23. Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis.
Zhang Y; Sun C; Li Y; Qin J; Amancherla K; Jing Y; Hu Q; Liang K; Zhang Z; Ye Y; Huang LA; Nguyen TK; Egranov SD; Zhao Z; Wu A; Xi Y; Yao J; Hung MC; Calin GA; Cheng J; Lim B; Lehmann LH; Salem JE; Johnson DB; Curran MA; Yu D; Han L; Darabi R; Yang L; Moslehi JJ; Lin C
Sci Transl Med; 2022 Nov; 14(669):eabo1981. PubMed ID: 36322628
[TBL] [Abstract][Full Text] [Related]
24. Cardiac myosin-induced myocarditis: target recognition by autoreactive T cells requires prior activation of cardiac interstitial cells.
Pummerer CL; Grässl G; Sailer M; Bachmaier KW; Penninger JM; Neu N
Lab Invest; 1996 May; 74(5):845-52. PubMed ID: 8642780
[TBL] [Abstract][Full Text] [Related]
25. Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms.
Moslehi J; Lichtman AH; Sharpe AH; Galluzzi L; Kitsis RN
J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33645548
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of low-intensity pulsed ultrasound on immune checkpoint inhibitor-related myocarditis via fine-tuning CD4
Fu S; Guo Z; Xu X; Li Y; Choi S; Zhao P; Shen W; Gao F; Wang C; Chen S; Li Y; Tian J; Sun P
Cancer Immunol Immunother; 2024 Jan; 73(1):15. PubMed ID: 38236243
[TBL] [Abstract][Full Text] [Related]
27. MyD88 signaling controls autoimmune myocarditis induction.
Marty RR; Dirnhofer S; Mauermann N; Schweikert S; Akira S; Hunziker L; Penninger JM; Eriksson U
Circulation; 2006 Jan; 113(2):258-65. PubMed ID: 16401773
[TBL] [Abstract][Full Text] [Related]
28. Heart-Specific Immune Responses in an Animal Model of Autoimmune-Related Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation.
Bockstahler M; Fischer A; Goetzke CC; Neumaier HL; Sauter M; Kespohl M; Müller AM; Meckes C; Salbach C; Schenk M; Heuser A; Landmesser U; Weiner J; Meder B; Lehmann L; Kratzer A; Klingel K; Katus HA; Kaya Z; Beling A
Circulation; 2020 Jun; 141(23):1885-1902. PubMed ID: 32160764
[TBL] [Abstract][Full Text] [Related]
29. Host-specific differences in top-expanded TCR clonotypes correlate with divergent outcomes of anti-PD-L1 treatment in responders versus non-responders.
John J; Chen SMY; Woolaver RA; Ge H; Vashisht M; Huang Z; Chen Z; Wang JH
Front Immunol; 2023; 14():1100520. PubMed ID: 37051229
[TBL] [Abstract][Full Text] [Related]
30. Mediators and mechanisms of immune checkpoint inhibitor-associated myocarditis: Insights from mouse and human.
Gong J; Neilan TG; Zlotoff DA
Immunol Rev; 2023 Sep; 318(1):70-80. PubMed ID: 37449556
[TBL] [Abstract][Full Text] [Related]
31. Divergent outcomes of anti-PD-L1 treatment coupled with host-intrinsic differences in TCR repertoire and distinct T cell activation states in responding versus non-responding tumors.
John J; Woolaver RA; Popolizio V; Chen SMY; Ge H; Krinsky AL; Vashisht M; Kramer Y; Chen Z; Wang JH
Front Immunol; 2022; 13():992630. PubMed ID: 36330507
[TBL] [Abstract][Full Text] [Related]
32. Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.
Durgeau A; Virk Y; Corgnac S; Mami-Chouaib F
Front Immunol; 2018; 9():14. PubMed ID: 29403496
[TBL] [Abstract][Full Text] [Related]
33. Clonality of CD4
Arakawa A; Vollmer S; Tietze J; Galinski A; Heppt MV; Bürdek M; Berking C; Prinz JC
Front Immunol; 2019; 10():1336. PubMed ID: 31275310
[TBL] [Abstract][Full Text] [Related]
34. Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease.
Bachmaier K; Pummerer C; Kozieradzki I; Pfeffer K; Mak TW; Neu N; Penninger JM
Circulation; 1997 Feb; 95(3):655-61. PubMed ID: 9024154
[TBL] [Abstract][Full Text] [Related]
35.
Boughdad S; Latifyan S; Fenwick C; Bouchaab H; Suffiotti M; Moslehi JJ; Salem JE; Schaefer N; Nicod-Lalonde M; Costes J; Perreau M; Michielin O; Peters S; Prior JO; Obeid M
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34686542
[TBL] [Abstract][Full Text] [Related]
36. T cells with similar T-cell receptor beta-chain complementarity-determining region 3 motifs infiltrate inflammatory lesions of synthetic peptides inducing rat autoimmune myocarditis.
Hanawa H; Inomata T; Okura Y; Hirono S; Ogawa Y; Izumi T; Kodama M; Aizawa Y
Circ Res; 1998 Jul; 83(2):133-40. PubMed ID: 9686752
[TBL] [Abstract][Full Text] [Related]
37. Cellular immune mechanisms in myosin-induced myocarditis.
Pummerer C; Grässl G; Neu N
Eur Heart J; 1995 Dec; 16 Suppl O():71-4. PubMed ID: 8682107
[TBL] [Abstract][Full Text] [Related]
38. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes.
Love VA; Grabie N; Duramad P; Stavrakis G; Sharpe A; Lichtman A
Circ Res; 2007 Aug; 101(3):248-57. PubMed ID: 17569889
[TBL] [Abstract][Full Text] [Related]
39. Exacerbation of autoimmune myocarditis by an immune checkpoint inhibitor is dependent on its time of administration in mice.
Tsuruoka K; Wakabayashi S; Morihara H; Matsunaga N; Fujisaka Y; Goto I; Imagawa A; Asahi M
Int J Cardiol; 2020 Aug; 313():67-75. PubMed ID: 32402518
[TBL] [Abstract][Full Text] [Related]
40. Myosin autoimmunity is not essential for cardiac inflammation in acute Chagas' disease.
Leon JS; Wang K; Engman DM
J Immunol; 2003 Oct; 171(8):4271-7. PubMed ID: 14530351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
